Director at Crocs (NASDAQ: CROX) receives 1,252-share annual grant

Rhea-AI Filing Summary

REPLOGLE JOHN B reported acquisition or exercise transactions in this Form 4 filing.

Crocs, Inc. director John B. Replogle received a stock-based compensation award of 1,252 shares of common stock on June 9, 2026. The shares were granted at no cash cost as the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, and increased his direct holdings to 19,669 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider REPLOGLE JOHN B

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,252	$0.00	--

Holdings After Transaction: Common Stock — 19,669 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Director stock grant: 1,252 shares Grant price: $0.00 per share Holdings after grant: 19,669 shares

3 metrics

Director stock grant 1,252 shares Annual common stock grant to non-employee director on June 9, 2026

Grant price $0.00 per share Compensation award, not an open-market purchase

Holdings after grant 19,669 shares Total Crocs common stock directly owned by John B. Replogle after transaction

Key Terms

non-employee directors, Board of Directors Compensation Plan, Grant, award, or other acquisition

3 terms

non-employee directors financial

"Represents the annual common stock grant to non-employee directors pursuant to the issuer's Board of Directors Compensation Plan."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Board of Directors Compensation Plan financial

"Represents the annual common stock grant to non-employee directors pursuant to the issuer's Board of Directors Compensation Plan."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REPLOGLE JOHN B

(Last) (First) (Middle)

C/O CROCS, INC.

500 ELDORADO BLVD #5

(Street)

BROOMFIELD COLORADO 80021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		1,252(1)	A	$0	19,669	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the annual common stock grant to non-employee directors pursuant to the issuer's Board of Directors Compensation Plan.

Remarks:

	/s/Sara Hoverstock, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Crocs (CROX) director John B. Replogle report?

John B. Replogle reported receiving 1,252 shares of Crocs common stock as a stock grant. The award was issued as part of his annual non-employee director compensation, rather than an open-market share purchase, and reflects equity-based pay for board service.

Was the Crocs (CROX) director stock grant an open-market purchase?

No, the 1,252 shares reported by John B. Replogle were granted at no cash cost as compensation. The filing describes the award as the annual common stock grant to non-employee directors under Crocs’ Board of Directors Compensation Plan.

How many Crocs (CROX) shares does John B. Replogle hold after the grant?

After receiving the 1,252-share stock grant, John B. Replogle directly holds 19,669 shares of Crocs common stock. This total reflects his updated ownership position reported in the Form 4 following the non-employee director equity award.

What is the transaction code used in this Crocs (CROX) Form 4 filing?

The transaction is coded “A” for an acquisition by grant, award, or other form of acquisition. This indicates the shares were received as a compensation-related grant, not bought or sold on the open market, consistent with director equity awards.

How is the Crocs (CROX) non-employee director grant described in the filing?

The footnote states the 1,252 shares represent the annual common stock grant to non-employee directors. It specifies this award is made pursuant to Crocs’ Board of Directors Compensation Plan, clarifying that the issuance is part of standard board compensation.